These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4772416)

  • 1. [Plasma viscosity and portal hypertension in liver cirrhosis (author's transl)].
    Leonhardt H; Bungert HJ
    Klin Wochenschr; 1973 Nov; 21(1):1043-9. PubMed ID: 4772416
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes of blood-flow properties in patients with chronic liver disease (author's transl)].
    Palme G; Kochen M; Leonhardt H
    Clin Chim Acta; 1975 Jun; 61(2):163-9. PubMed ID: 1132147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On the diagnosis of imminent bleeding from esophageal varices (author's transl)].
    Bungert HJ
    Leber Magen Darm; 1973 Dec; 3(6):242-8. PubMed ID: 4544843
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood and plasma viscosity in liver cirrhosis (author's transl)].
    Leonhardt H; Bungert HJ
    Wien Klin Wochenschr; 1974 Jan; 86(1):21-2. PubMed ID: 4140620
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood coagulation disorders in liver cirrhosis in relation to the degree of portal hypertension].
    Klingemann HG; Schmidt U; Brunswig D; Egbring R; Kaffarnik H
    Fortschr Med; 1980 Oct; 98(40):1561-66. PubMed ID: 6970156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum tests, liver stiffness and artificial neural networks for diagnosing cirrhosis and portal hypertension.
    Procopet B; Cristea VM; Robic MA; Grigorescu M; Agachi PS; Metivier S; Peron JM; Selves J; Stefanescu H; Berzigotti A; Vinel JP; Bureau C
    Dig Liver Dis; 2015 May; 47(5):411-6. PubMed ID: 25732434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of prostacyclin in patients with portal hypertension.
    Hashizume M; Inokuchi K; Tanaka K
    Liver; 1985 Apr; 5(2):89-93. PubMed ID: 3889532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oral arterial ammonia test in cirrhosis of the liver, with a note on the role of esophageal varices.
    Gips CH; Qué GS
    Acta Hepatogastroenterol (Stuttg); 1974 Feb; 21(1):20-5. PubMed ID: 4471687
    [No Abstract]   [Full Text] [Related]  

  • 9. Disordered hemostasis in extrahepatic portal hypertension.
    Robson SC; Kahn D; Kruskal J; Bird AR; Kirsch RE
    Hepatology; 1993 Oct; 18(4):853-7. PubMed ID: 8406359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor levels in liver cirrhosis.
    Genesca J; González A; Mujal A; Cereto F; Segura R
    Dig Dis Sci; 1999 Jun; 44(6):1261-2. PubMed ID: 10389707
    [No Abstract]   [Full Text] [Related]  

  • 11. Interrelationship between insulin resistance and portal haemodynamic abnormality in cirrhosis.
    Maruyama H; Kobayashi K; Kiyono S; Yokosuka O
    Int J Med Sci; 2017; 14(3):240-245. PubMed ID: 28367084
    [No Abstract]   [Full Text] [Related]  

  • 12. Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis.
    Lisotti A; Azzaroli F; Buonfiglioli F; Montagnani M; Cecinato P; Turco L; Calvanese C; Simoni P; Guardigli M; Arena R; Cucchetti A; Colecchia A; Festi D; Golfieri R; Mazzella G
    Hepatology; 2014 Feb; 59(2):643-50. PubMed ID: 24038116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxic elevation of serum growth hormone levels after splenectomy and/or paraesophagogastric devascularization in patients with portal hypertension.
    Iwasaki Y; Satoh H; Tsushima T; Ohkubo A; Matsuzaki F; Kosaka K; Beppu T; Futagawa S; Sugiura M
    Metabolism; 1980 Jun; 29(6):568-74. PubMed ID: 6991859
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of fibrinogen synthesis in portal hypertension.
    Grün M; Liehr H; Brunswig D; Thiel H
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):292-305. PubMed ID: 4450188
    [No Abstract]   [Full Text] [Related]  

  • 15. [Percutaneous transhepatic obliteration of gastroesophageal varices in liver cirrhosis (author's transl)].
    Sugiki K; Nakao N; Takayasu Y; Miura K; Miura T; Kyo A; Shu A; Ishikawa Y
    Rinsho Hoshasen; 1979 Dec; 24(13):1479-85. PubMed ID: 522279
    [No Abstract]   [Full Text] [Related]  

  • 16. [Free amino acids in the serum of portal hypertension patients].
    Kataeva GA; Eremenko VP
    Vestn Khir Im I I Grek; 1971 Apr; 106(4):10-4. PubMed ID: 5565362
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of the von Willebrand factor and the VITRO score as predictors for variceal bleeding in patients with hepatitis C-related cirrhosis.
    Ibrahim EH; Marzouk SA; Zeid AE; Lashen SA; Taher TM
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):241-247. PubMed ID: 30281535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Portal hypertension, size of esophageal varices, risk of gastrointestinal bleeding, extra-hepatic uptake of 99m technetium phytate in cirrhotic patients (author's transl)].
    Bretagne JF; Dartois M; Duvauferrier R; Gosselin M; Gastard J
    Gastroenterol Clin Biol; 1982 May; 6(5):467-71. PubMed ID: 6980159
    [No Abstract]   [Full Text] [Related]  

  • 19. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis.
    Berzigotti A; Seijo S; Arena U; Abraldes JG; Vizzutti F; García-Pagán JC; Pinzani M; Bosch J
    Gastroenterology; 2013 Jan; 144(1):102-111.e1. PubMed ID: 23058320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive model predicting clinically-significant portal hypertension in patients with advanced fibrosis.
    Park SH; Park TE; Kim YM; Kim SJ; Baik GH; Kim JB; Kim DJ
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1289-93. PubMed ID: 19682196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.